Page last updated: 2024-08-17

nad and linezolid

nad has been researched along with linezolid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Adossa, N; Almeida, L; Berod, L; Blazar, BR; Carriche, GM; Castro, CN; Dennerlein, S; Dhillon-LaBrooy, A; Guderian, M; Hesse, C; Kalesse, M; Lambrecht, BN; Lippens, S; Moita, LF; Müller, R; Schauser, L; Sparwasser, T	1

Other Studies

1 other study(ies) available for nad and linezolid

Article	Year
Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis. Immunity, 2021, 01-12, Volume: 54, Issue:1 Topics: Animals; Anti-Bacterial Agents; Autoimmunity; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; Humans; Linezolid; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondrial Proteins; Molecular Targeted Therapy; Multiple Sclerosis; NAD; Oxidative Phosphorylation; Peptide Elongation Factor G; Peptides, Cyclic; Ribosomes; Th17 Cells	2021

Article

Year

Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis.

Immunity, 2021, 01-12, Volume: 54, Issue:1

Topics: Animals; Anti-Bacterial Agents; Autoimmunity; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; Humans; Linezolid; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondrial Proteins; Molecular Targeted Therapy; Multiple Sclerosis; NAD; Oxidative Phosphorylation; Peptide Elongation Factor G; Peptides, Cyclic; Ribosomes; Th17 Cells

2021